0001055726-20-000004.txt : 20200116 0001055726-20-000004.hdr.sgml : 20200116 20200116160927 ACCESSION NUMBER: 0001055726-20-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200115 FILED AS OF DATE: 20200116 DATE AS OF CHANGE: 20200116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shepard Jay CENTRAL INDEX KEY: 0001587788 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14888 FILM NUMBER: 20531025 MAIL ADDRESS: STREET 1: 15977 GRANDVIEW AVENUE CITY: MONTE SERENO STATE: CA ZIP: 95030 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001055726 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330969592 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584103134 MAIL ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP DATE OF NAME CHANGE: 20050404 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP DATE OF NAME CHANGE: 20011116 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD DATE OF NAME CHANGE: 19980213 4 1 wf-form4_157920894919990.xml FORM 4 X0306 4 2020-01-15 0 0001055726 INOVIO PHARMACEUTICALS, INC. INO 0001587788 Shepard Jay 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 1 0 0 0 Restricted Stock Unit 2020-01-15 4 A 0 12821 0 A Common Stock 12821.0 12821 D Common Stock Option 3.35 2020-01-15 4 A 0 20000 0 A 2030-01-15 Common Stock 20000.0 20000 D Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 12,821 restricted stock units is as follows: 4,274 shares will vest on January 15, 2021; 4,274 shares will vest on January 15, 2022; 4,273 shares will vest on January 15, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. This grant was made pursuant to the issuer's non-employee director compensation policy. The vesting schedule for the 20,000 options is as follows: 5,000 shares vested on January 15, 2020; 5,000 shares will vest on January 15, 2021; 5,000 shares will vest on January 15, 2022; 5,000 shares will vest on January 15, 2023. /s/ Jay P. Shepard 2020-01-16